News
Hosted on MSN3mon
Semaglutide currently not cost-effective for heart patients without diabetes, study findsFor overweight or obese individuals without ... of life between those treated with semaglutide and those who did not receive semaglutide. "The main finding is that at current pricing, semaglutide ...
9don MSN
New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results